中国脐血库公共库与私人库的紧张态势.pdfVIP

中国脐血库公共库与私人库的紧张态势.pdf

  1. 1、本文档共11页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
中国脐血库公共库与私人库的紧张态势.pdf

East Asian Science, Technology and Society: An International Journal (2011) 5:329–339 DOI 10.12151408076 Cord-Blood Banking in China: Public and Private Tensions Haidan Chen Received: 9 July 2010 / Accepted: 28 January 2011 q National Science Council, Taiwan 2011 Abstract Cord-blood banking has become an important component in the develop- ment of stem-cell innovation and regenerative medicine, but this field is also charac- terized by acute uncertainty. This essay explores China’s public–private banking model through an empirical case study of the Tianjin Cord Blood Bank. I argue that the Chinese model of “using banks to pay for banks” reflects a mutation in contem- porary biopolitics. This model could help solve funding problems in the collection of public cord blood, but it also creates public–private tensions and dilemmas within the cord-blood economy. Thus, robust and strict regulations are needed to encourage the development of biomedical innovation while protecting the public interest in China. Keywords cord blood stem cells blood bank biopolitics China 1 Introduction The burgeoning interest in stem cells and regenerative medicine has made the collec- tion of umbilical cord blood a topic of great and controversial interest. Once con- sidered waste, umbilical cord blood now is recognized as a clinically valuable biological material and is used as a substitute for bone marrow in the treatment of blood diseases (Waldby and Mitchell 2006). The first cord-blood transplant was per- formed in France in 1988. A six-year-old boy with severe Fanconi anemia received umbilical cord blood from a younger sister with identical human leukocyte antigens (HLA), subsequently regaining his health (Gluckman et al. 1989). Since that time, more than 3,500 cord-blood transplants have been performed worldwide (Warwick and Armitage 2004). Cord blood has several advantages over bone marrow: it is harvested at

文档评论(0)

ziyouzizai + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档